In addition, the meta-analysis of Yusof et al. (19) reported a mutation prevalence of 70.49% in the BRAF V600E gene in patients with ameloblastoma, a rate very similar to that reported in the present study. The gene discussed is BRAF; the disease is ameloblastoma.